ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 815

Netosis Induced Histone Citrullination Facilitates Onset and Propagation of Rheumatoid Arthritis

Dong Hyun Sohn1, Kazuhiro Onuma1, Chris Rhodes1, Xioayan Zhao1, Tal Gazitt2, Rani Shiao1, Justyna Fert Bober3, Danye Cheng1, Lauren J. Lahey1, Heidi Wong4, Jennifer van Eyk3, William H. Robinson1,5 and Jeremy Sokolove1, 1VA Palo Alto Healthcare System and Stanford University, Palo Alto, CA, 2Rheumatology, University of Washington, Seattle, WA, 3Johns Hopkins University and Cedars Sinai Medical Center, Los Angeles, CA, 4Stanford University School of Medicine, Stanford, CA, 5Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: ACPA, NETosis, pathogenesis and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: ACR Plenary Session I: Discovery 2014

Session Type: Plenary Sessions

Background/Purpose:   Anti-citrullinated protein antibodies (ACPAs) are characteristic of rheumatoid arthritis however, their presence years before onset of clinical RA is perplexing.  Although multiple putative citrullinated antigens have been identified, including citrullinated products of NETosis, no studies have demonstrated the capacity of these antigens to initiate inflammatory arthritis.  We sought to identify citrullinated products of NETosis targeted by the RA immune response and with the capacity to drive inflammatory arthritis.

 

Methods:   We performed proteomic analysis of human NETs to identify all citrullinated proteins including those targeted as part of the RA immune response.  Using a combination of ELISA and IHC we compared RA and OA serum, synovial fluid and synovial tissue for levels of histone 2B (H2B), anti-H2B antibodies, as well as H2B-containing immune complexes.  Using macrophage activation assays we assessed the effect of histone citrullination on immunostimulatory capacity and evaluated the stimulatory capacity of native and citrullinated H2B-containing immune complexes.  Finally, we immunized mice with citrullinated H2B (cH2B) with and without the induction of low grade collagen induced arthritis to assess the potential for anti-cH2B antibodies to mediate arthritis in vivo.

 

Results:   Proteomic interrogation of NET-derived proteins, RA serum, synovium, and synovial fluid identified robust targeting of NET-derived citrullinated histones by the ACPA immune response.  Over 90% of RA patients have anti-cH2B antibodies and over half have measurable levels of synovial fluid H2B immune complexes.  We observe that histone citrullination increases innate immunostimulatory capacity and that immune complexes containing citrullinated histones both activate macrophage cytokine production and propagate NETosis.  Finally, we demonstrate that autoimmunity to cH2B is arthritogenic, both by primary immunization as well as immune serum transfer, but only in the setting of underlying low grade articular inflammation.

 

Conclusion:   We identify cH2B as an antigenic target of the ACPA immune response and our findings suggest that intra-articular histone citrullination can link innate immunity via NETosis and adaptive immunity via generation of citrullinated histone immune complexes.  The generation of citrullinated histone antigens during low grade articular inflammation provides a potential mechanism for the conversion from asymptomatic ACPA seropositivity to clinical RA.

 

NET blot for ACR

paw scores for ACR 2014 NET abstract


Disclosure:

D. H. Sohn,
None;

K. Onuma,
None;

C. Rhodes,
None;

X. Zhao,
None;

T. Gazitt,
None;

R. Shiao,
None;

J. Fert Bober,
None;

D. Cheng,
None;

L. J. Lahey,
None;

H. Wong,
None;

J. van Eyk,
None;

W. H. Robinson,
None;

J. Sokolove,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/netosis-induced-histone-citrullination-facilitates-onset-and-propagation-of-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology